Tekla Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-114,119
Closed -$6.48M 193
2021
Q2
$6.48M Hold
114,119
0.21% 107
2021
Q1
$8.54M Sell
114,119
-37,921
-25% -$2.84M 0.29% 91
2020
Q4
$13.2M Buy
152,040
+55,829
+58% +$4.83M 0.46% 63
2020
Q3
$5.88M Hold
96,211
0.22% 99
2020
Q2
$4M Hold
96,211
0.15% 112
2020
Q1
$2.76M Hold
96,211
0.12% 118
2019
Q4
$6.95M Buy
96,211
+9,431
+11% +$681K 0.26% 82
2019
Q3
$12.2M Buy
86,780
+2,635
+3% +$370K 0.53% 47
2019
Q2
$15.4M Buy
84,145
+4,289
+5% +$785K 0.63% 36
2019
Q1
$12.7M Sell
79,856
-18,588
-19% -$2.96M 0.52% 45
2018
Q4
$9.43M Sell
98,444
-45,170
-31% -$4.33M 0.4% 50
2018
Q3
$20.3M Hold
143,614
0.74% 35
2018
Q2
$22.5M Buy
143,614
+18,964
+15% +$2.97M 0.85% 33
2018
Q1
$20.1M Buy
124,650
+56,835
+84% +$9.15M 0.78% 32
2017
Q4
$11.2M Buy
+67,815
New +$11.2M 0.43% 52
2017
Q3
Sell
-90,480
Closed -$7.21M 158
2017
Q2
$7.21M Hold
90,480
0.27% 71
2017
Q1
$6.43M Buy
90,480
+36,480
+68% +$2.59M 0.25% 73
2016
Q4
$2.76M Sell
54,000
-92,800
-63% -$4.74M 0.12% 93
2016
Q3
$6.76M Hold
146,800
0.26% 76
2016
Q2
$4.42M Hold
146,800
0.18% 87
2016
Q1
$4.71M Buy
146,800
+49,000
+50% +$1.57M 0.2% 88
2015
Q4
$5.7M Hold
97,800
0.21% 86
2015
Q3
$4.14M Buy
97,800
+82,800
+552% +$3.5M 0.15% 95
2015
Q2
$1.1M Hold
15,000
0.04% 97
2015
Q1
$753K Buy
15,000
+10,000
+200% +$502K 0.03% 97
2014
Q4
$183K Hold
5,000
0.01% 91
2014
Q3
$158K Buy
+5,000
New +$158K 0.01% 92